Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02617849
Title Pembrolizumab With Carboplatin/Paclitaxel in Patients With Metastatic Melanoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Wilson Miller
Indications
Therapies
Age Groups: adult | senior
Covered Countries CAN

Facility Status City State Zip Country Details
Jewish General Hospital Montreal Quebec H3T 1E2 Canada Details
Hopital Notre-Dame Montreal Quebec Canada Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field